Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | DRL_RI |
Synonyms | |
Therapy Description |
DRL_RI is a potential biosimilar of rituximab, which may lead to complement and antibody-dependent cytotoxicity towards CD20-positive tumor cells (PMID: 31809224). |